Tetraarsenic Tetrasulfide
Active ingredient
Sold as Arsenicum sulphuratum…
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 1
- FDA reports (12 mo)
- 1
Overview
Plain-language summary, compiled from the cited regulatory records
Tetraarsenic Tetrasulfide is an active ingredient indicated for the relief of dry cough associated with hypersensitivity to cold [1]. It is available under brand names such as Arsenicum sulphuratum rubrun [1].
While specific drug class information is not available in the provided data, Tetraarsenic Tetrasulfide is recognized for its use in certain therapeutic contexts [1]. In the past 12 months, there has been 1 adverse event report associated with this ingredient [2]. The top reported reactions include "Therapy Non-Responder" and "Treatment Noncompliance" [2]. These reports do not constitute a complete list of all possible adverse events [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | April 12, 2024 |
USUnited States· FDA
1 product
Uses
Uses:
See symptoms on front panel. Relieves dry cough with hypersensitivity to cold *
How to take
Sources & citations
- [1]FDA DailyMed · 15e96c96-2b15-f6… · revised April 12, 2024 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.